Tracers / [177Lu]Lu-OncoFAP-DOTAGA
[177Lu]Lu-OncoFAP-DOTAGA
Also written as [177Lu]Lu-OncoFAP-DOTAGA
- Radionuclide
- Lu-177 t½ 9576 min
- Modality
- Therapy
- Production route
- Reactor
- Stage
- Research
- Syntheses indexed
- 0
What it is
- Compound class
- Small molecule chelate
- Target / mechanism
- FAP PMID 34957527 / DOI 10.1007/s00259-021-05653-0
- Clinical application
- (preclinical) FAP-directed radioligand therapy of solid tumours PMID 36015106 / DOI 10.3390/ph15080958
- Theranostic pair
- <a href="/tracers/ga68-oncofap-dotaga/">ga68-oncofap-dotaga</a>
Regulatory status
- FDA
- No Drugs@FDA / openFDA drug registry — no approved application found; search: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=OncoFAP
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
No synthesis has been parsed for this agent yet.
Precursor
- Common precursor
- DOTAGA-OncoFAP conjugate (from OncoFAP-COOH); labelled with 177Lu PMID 36015106 / DOI 10.3390/ph15080958
- Suppliers seen in the literature
- —
- Typical final purification
- SPE
Need this precursor?We can point you to suppliers for [177Lu]Lu-OncoFAP-DOTAGA, or handle the enquiry for you.
Get in touchQuality control Preliminary — inferred from compound class
- Ph. Eur. monograph
- —
- USP monograph
- —
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); Lu-177 preparation -> Lu-177m content (rule); therapeutic radiopharmaceutical -> osmolality (rule); receptor ligand with a saturable target -> molar activity (rule)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [177Lu]Lu-OncoFAP-DOTAGA.
Get in touch